A study at two US medical centers found that patients with brain metastases from gastrointestinal (GI) cancers had significantly worse overall survival and intracranial progression-free survival (PFS) ...

A recent analysis assesses whether romiplostim can reduce thrombocytopenia-driven chemotherapy dose reductions, delays, and discontinuations.

Tiago Biachi, MD, PhD, highlighted the transformative role of personalized medicine in gastrointestinal (GI) cancer treatment through advances in next-generation sequencing and circulating tumor DNA, ...

Overall, 88% of patients were malnourished at baseline. The prevalence of malnutrition is high among patients with gastrointestinal (GI) cancer and most patients are malnourished at the time of ...

Early-onset gastrointestinal cancers represent the most rapidly increasing early-onset cancer in the U.S. Colorectal cancer is the most common early-onset GI cancer, but pancreatic, gastric, and ...

Cancers affecting the digestive system are becoming increasingly common worldwide. Many of these cancers develop slowly and may not cause clear symptoms in the early stages. Because the signs often ...

ArriVent Biopharma, a company that secures rights to drugs from emerging markets to develop them for Western markets, is adding to its pipeline with a Phase 1-ready drug candidate from China that has ...

Social media is usually rife with misinformation about how to boost health, and various tricks to your improve your digestion and gut microbiome are no exception.